More articles from psychopharmacology for the clinician

Open Access
Population pharmacokinetics and dosing of long-acting injectable antipsychotics
David D. Kim, Alasdair M. Barr, Reza Rafizadeh and Ric M. Procyshyn

J Psychiatry Neurosci September 01, 2021 46 (5) E516-E517; DOI: https://doi.org/10.1503/jpn.210079
You have access
Oculogyric crisis: a rare type of dystonia
Sara Boi, Celia Garcia-Malo and Carmen Iglesias Rodríguez

J Psychiatry Neurosci July 01, 2021 46 (4) E429-E430; DOI: https://doi.org/10.1503/jpn.210026
You have access
Use of MAOIs in severe treatment-resistant depression: back to the old school
Jacob Cookey

J Psychiatry Neurosci July 01, 2021 46 (4) E427-E428; DOI: https://doi.org/10.1503/jpn.200214
You have access
To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians
Anna Muntingh, Neeltje Batelaan, Willemijn Scholten and Anton J. van Balkom

J Psychiatry Neurosci May 01, 2021 46 (3) E388-E389; DOI: https://doi.org/10.1503/jpn.200099
You have access
Serotonin syndrome: SSRIs are not the only culprit
Nicolas Garel, Kyle T. Greenway, Karim Tabbane and Ridha Joober

J Psychiatry Neurosci May 01, 2021 46 (3) E369-E370; DOI: https://doi.org/10.1503/jpn.210001
Open Access
Binge eating disorder hidden behind a wall of anxiety disorders
Amy Pipe, Beth Patterson and Michael Van Ameringen

J Psychiatry Neurosci March 01, 2021 46 (2) E208-E209; DOI: https://doi.org/10.1503/jpn200235
Open Access
Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination
Deborah Thompson, Clay M. Delorme, Randall F. White and William G. Honer

J Psychiatry Neurosci March 01, 2021 46 (2) E210-E211; DOI: https://doi.org/10.1503/jpn.210027
You have access
The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
Nicolas Garel, Kyle T. Greenway and Ridha Joober

J Psychiatry Neurosci January 01, 2021 46 (1) E164-E165; DOI: https://doi.org/10.1503/jpn.200114
You have access
Therapeutic abstention in the treatment of depression in first-episode psychosis
Priyadharshini Sabesan and Lena Palaniyappan

J Psychiatry Neurosci November 01, 2020 45 (6) 441-442; DOI: https://doi.org/10.1503/jpn.200059
You have access
Treating anxious syndromes with pregabalin in patients with psychosis
Nicolas Garel, David Bloom and Ridha Joober

J Psychiatry Neurosci September 01, 2020 45 (5) 370; DOI: https://doi.org/10.1503/jpn.200033

Main menu

User menu

Search

More articles from psychopharmacology for the clinician

Pages

Content

Authors & Reviewers

About